To gain a global understanding of the impact of TREM1 silencing, we analyzed the CD45+ tumor-infiltrating cells (TICs) of B16F10 tumor-bearing Trem1+/+ and Trem1–/– mice. The gene discussed is PTPRC; the disease is neoplasm.